_id
6911c9fdccc777a4e85d671a
Ticker
IBXXF
Name
Imagion Biosystems Limited
Exchange
PINK
Address
Suite 2, Melbourne, VIC, Australia, 3000
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://imagionbiosystems.com
Description
Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It is involved in the nanotechnology; biotechnology; and cancer diagnostics businesses. The company develops MagSense, which completed Phase 1 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to detect cancer. The company has collaboration with Siemens MRI to support the Phase 2 study of MagSense HER2 imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Last Close
0.01
Volume
-
Current Price
0.01
Change
0
Last Updated
2026-01-04T14:56:25.388Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
7102946
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
25734
Cost Of Revenue
611595
Gross Profit
-585861
Operating Expenses
1172905
Operating Income
-1758766
Interest Expense
677993
Pretax Income
-1661455
Net Income
-1661455
Eps
-0.008251928695345665
Dividends Per Share
-
Shares Outstanding
486141755
Income Tax Expense
-
EBITDA
-1147171
Operating Margin
-6834.405844408176
Total Other Income Expense Net
97311
Cash
883565
Short Term Investments
-
Receivables
884
Inventories
-
Total Current Assets
919430
Property Plant Equipment
13045
Total Assets
932475
Payables
1497558
Short Term Debt
3300711
Long Term Debt
-
Total Liabilities
4798269
Equity
-3865794
Bs_currency_symbol
-
Depreciation
4443
Change In Working Capital
-
Cash From Operations
-1777280
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
883565
Cf_currency_symbol
-
PE
-
PB
-0.5208281015491255
ROE
42.97836356515634
ROA
-178.1768948229175
FCF
-1777280
Fcf Percent
-69.06349576435844
Piotroski FScore
0
Health Score
30
Deep Value Investing Score
1.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
4
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
25734
Quarters > 0 > income Statement > cost Of Revenue
611595
Quarters > 0 > income Statement > gross Profit
-585861
Quarters > 0 > income Statement > operating Expenses
1172905
Quarters > 0 > income Statement > operating Income
-1758766
Quarters > 0 > income Statement > interest Expense
677993
Quarters > 0 > income Statement > pretax Income
-1661455
Quarters > 0 > income Statement > net Income
-1661455
Quarters > 0 > income Statement > eps
-0.008251928695345665
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
201341415
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1147171
Quarters > 0 > income Statement > operating Margin
-6834.405844408176
Quarters > 0 > income Statement > total Other Income Expense Net
97311
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
883565
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
884
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
919430
Quarters > 0 > balance Sheet > property Plant Equipment
13045
Quarters > 0 > balance Sheet > total Assets
932475
Quarters > 0 > balance Sheet > payables
1497558
Quarters > 0 > balance Sheet > short Term Debt
3300711
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4798269
Quarters > 0 > balance Sheet > equity
-3865794
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-1661455
Quarters > 0 > cash Flow > depreciation
4443
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-1777280
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
883565
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.008251928695345665
Quarters > 0 > ratios > PB
-0.5208281015491255
Quarters > 0 > ratios > ROE
42.97836356515634
Quarters > 0 > ratios > ROA
-178.1768948229175
Quarters > 0 > ratios > FCF
-1777280
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-69.06349576435844
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1030087
Quarters > 1 > income Statement > cost Of Revenue
68183
Quarters > 1 > income Statement > gross Profit
961904
Quarters > 1 > income Statement > operating Expenses
847294
Quarters > 1 > income Statement > operating Income
114610
Quarters > 1 > income Statement > interest Expense
66475
Quarters > 1 > income Statement > pretax Income
-540128
Quarters > 1 > income Statement > net Income
-540128
Quarters > 1 > income Statement > eps
-0.00943101980462126
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
57271431
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-161775
Quarters > 1 > income Statement > operating Margin
11.126244676420535
Quarters > 1 > income Statement > total Other Income Expense Net
-654738
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
2670517
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
886
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2785445
Quarters > 1 > balance Sheet > property Plant Equipment
18274
Quarters > 1 > balance Sheet > total Assets
2803719
Quarters > 1 > balance Sheet > payables
2074245
Quarters > 1 > balance Sheet > short Term Debt
2847301
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
5086699
Quarters > 1 > balance Sheet > equity
-2282980
Quarters > 1 > balance Sheet > currency_symbol
AUD
Quarters > 1 > cash Flow > net Income
-540128
Quarters > 1 > cash Flow > depreciation
7740
Quarters > 1 > cash Flow > change In Working Capital
72800
Quarters > 1 > cash Flow > cash From Operations
-1113669
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
3389807
Quarters > 1 > cash Flow > net Change In Cash
-382450
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.00943101980462126
Quarters > 1 > ratios > PB
-0.2508626050162507
Quarters > 1 > ratios > ROE
23.65890196147141
Quarters > 1 > ratios > ROA
-19.264698067103016
Quarters > 1 > ratios > FCF
-1113669
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-1.081140719181972
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1635048
Quarters > 2 > income Statement > cost Of Revenue
332853
Quarters > 2 > income Statement > gross Profit
1302195
Quarters > 2 > income Statement > operating Expenses
2173358
Quarters > 2 > income Statement > operating Income
-871166
Quarters > 2 > income Statement > interest Expense
1208412
Quarters > 2 > income Statement > pretax Income
-1526830
Quarters > 2 > income Statement > net Income
-1526830
Quarters > 2 > income Statement > eps
-0.04680003249086961
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
32624550
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-538310
Quarters > 2 > income Statement > operating Margin
-53.28075995322461
Quarters > 2 > income Statement > total Other Income Expense Net
-655664
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
382450
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
916
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
496902
Quarters > 2 > balance Sheet > property Plant Equipment
25821
Quarters > 2 > balance Sheet > total Assets
522723
Quarters > 2 > balance Sheet > payables
2590291
Quarters > 2 > balance Sheet > short Term Debt
3183770
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
5796631
Quarters > 2 > balance Sheet > equity
-5273908
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-1526829
Quarters > 2 > cash Flow > depreciation
384313
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-156942
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
83744
Quarters > 2 > cash Flow > cash From Financing
220000
Quarters > 2 > cash Flow > net Change In Cash
155366
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.04680003249086961
Quarters > 2 > ratios > PB
-0.06186029411207022
Quarters > 2 > ratios > ROE
28.950637743396356
Quarters > 2 > ratios > ROA
-292.09160492268376
Quarters > 2 > ratios > FCF
-156946
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.0959886192943571
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
746669
Quarters > 3 > income Statement > cost Of Revenue
3042279
Quarters > 3 > income Statement > gross Profit
1238465
Quarters > 3 > income Statement > operating Expenses
8202408
Quarters > 3 > income Statement > operating Income
-8054500
Quarters > 3 > income Statement > interest Expense
730523
Quarters > 3 > income Statement > pretax Income
-8324915
Quarters > 3 > income Statement > net Income
-4790840
Quarters > 3 > income Statement > eps
-0.14674873312038383
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
32646551
Quarters > 3 > income Statement > income Tax Expense
-3534075
Quarters > 3 > income Statement > EBITDA
-6995631
Quarters > 3 > income Statement > operating Margin
-1078.7243075579674
Quarters > 3 > income Statement > total Other Income Expense Net
-270415
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
227084
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
73686
Quarters > 3 > balance Sheet > inventories
142649
Quarters > 3 > balance Sheet > total Current Assets
601380
Quarters > 3 > balance Sheet > property Plant Equipment
3984892
Quarters > 3 > balance Sheet > total Assets
4586272
Quarters > 3 > balance Sheet > payables
1590171
Quarters > 3 > balance Sheet > short Term Debt
2795646
Quarters > 3 > balance Sheet > long Term Debt
750000
Quarters > 3 > balance Sheet > total Liabilities
8374319
Quarters > 3 > balance Sheet > equity
-3788047
Quarters > 3 > balance Sheet > currency_symbol
AUD
Quarters > 3 > cash Flow > net Income
-4790840
Quarters > 3 > cash Flow > depreciation
598760
Quarters > 3 > cash Flow > change In Working Capital
185372
Quarters > 3 > cash Flow > cash From Operations
-2296399
Quarters > 3 > cash Flow > capital Expenditures
166852
Quarters > 3 > cash Flow > cash From Investing
-166852
Quarters > 3 > cash Flow > cash From Financing
2269550
Quarters > 3 > cash Flow > net Change In Cash
-226476
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.14674873312038383
Quarters > 3 > ratios > PB
-0.08618306742234191
Quarters > 3 > ratios > ROE
126.472559606573
Quarters > 3 > ratios > ROA
-104.46044194500456
Quarters > 3 > ratios > FCF
-2463251
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-3.2989865656669823
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2665135
Annuals > 0 > income Statement > cost Of Revenue
401036
Annuals > 0 > income Statement > gross Profit
2264099
Annuals > 0 > income Statement > operating Expenses
3020652
Annuals > 0 > income Statement > operating Income
-756553
Annuals > 0 > income Statement > interest Expense
1141937
Annuals > 0 > income Statement > pretax Income
-2066957
Annuals > 0 > income Statement > net Income
-2066957
Annuals > 0 > income Statement > eps
-0.04598552580470171
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
44947991
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-700085
Annuals > 0 > income Statement > operating Margin
-28.387042307425325
Annuals > 0 > income Statement > total Other Income Expense Net
-1310404
Annuals > 0 > income Statement > currency_symbol
AUD
Annuals > 0 > balance Sheet > cash
2670517
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
886
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2785445
Annuals > 0 > balance Sheet > property Plant Equipment
18274
Annuals > 0 > balance Sheet > total Assets
2803719
Annuals > 0 > balance Sheet > payables
2074245
Annuals > 0 > balance Sheet > short Term Debt
2847301
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5086699
Annuals > 0 > balance Sheet > equity
-2282980
Annuals > 0 > balance Sheet > currency_symbol
AUD
Annuals > 0 > cash Flow > net Income
-2066957
Annuals > 0 > cash Flow > depreciation
392053
Annuals > 0 > cash Flow > change In Working Capital
72800
Annuals > 0 > cash Flow > cash From Operations
-1270611
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
83744
Annuals > 0 > cash Flow > cash From Financing
3609807
Annuals > 0 > cash Flow > net Change In Cash
2443433
Annuals > 0 > cash Flow > currency_symbol
AUD
Annuals > 0 > ratios > PE
-0.04598552580470171
Annuals > 0 > ratios > PB
-0.19688298189208842
Annuals > 0 > ratios > ROE
90.5376744430525
Annuals > 0 > ratios > ROA
-73.72197427773611
Annuals > 0 > ratios > FCF
-1270611
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.47675295998138933
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
4970756
Annuals > 1 > income Statement > cost Of Revenue
5250591
Annuals > 1 > income Statement > gross Profit
-279835
Annuals > 1 > income Statement > operating Expenses
15534451
Annuals > 1 > income Statement > operating Income
-15814286
Annuals > 1 > income Statement > interest Expense
1127968
Annuals > 1 > income Statement > pretax Income
-12473916
Annuals > 1 > income Statement > net Income
-12473916
Annuals > 1 > income Statement > eps
-0.4092024389338174
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
30483484
Annuals > 1 > income Statement > income Tax Expense
-3534075
Annuals > 1 > income Statement > EBITDA
-10304971
Annuals > 1 > income Statement > operating Margin
-318.14649522125006
Annuals > 1 > income Statement > total Other Income Expense Net
3340370
Annuals > 1 > income Statement > currency_symbol
AUD
Annuals > 1 > balance Sheet > cash
227084
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
73686
Annuals > 1 > balance Sheet > inventories
142649
Annuals > 1 > balance Sheet > total Current Assets
601380
Annuals > 1 > balance Sheet > property Plant Equipment
3984892
Annuals > 1 > balance Sheet > total Assets
4586272
Annuals > 1 > balance Sheet > payables
1590171
Annuals > 1 > balance Sheet > short Term Debt
2795646
Annuals > 1 > balance Sheet > long Term Debt
750000
Annuals > 1 > balance Sheet > total Liabilities
8374319
Annuals > 1 > balance Sheet > equity
-3788047
Annuals > 1 > balance Sheet > currency_symbol
AUD
Annuals > 1 > cash Flow > net Income
-12473916
Annuals > 1 > cash Flow > depreciation
1183247
Annuals > 1 > cash Flow > change In Working Capital
2152984
Annuals > 1 > cash Flow > cash From Operations
-8315963
Annuals > 1 > cash Flow > capital Expenditures
190379
Annuals > 1 > cash Flow > cash From Investing
-190379
Annuals > 1 > cash Flow > cash From Financing
4291561
Annuals > 1 > cash Flow > net Change In Cash
-4219018
Annuals > 1 > cash Flow > currency_symbol
AUD
Annuals > 1 > ratios > PE
-0.4092024389338174
Annuals > 1 > ratios > PB
-0.08047282412282636
Annuals > 1 > ratios > ROE
329.2967589895268
Annuals > 1 > ratios > ROA
-271.98378116256515
Annuals > 1 > ratios > FCF
-8506342
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-1.7112773187820927
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3070925
Annuals > 2 > income Statement > cost Of Revenue
3615851
Annuals > 2 > income Statement > gross Profit
-544926
Annuals > 2 > income Statement > operating Expenses
11594211
Annuals > 2 > income Statement > operating Income
-12139137
Annuals > 2 > income Statement > interest Expense
1985
Annuals > 2 > income Statement > pretax Income
-9807208
Annuals > 2 > income Statement > net Income
-9809193
Annuals > 2 > income Statement > eps
-0.3499340831909194
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
28031545
Annuals > 2 > income Statement > income Tax Expense
1985
Annuals > 2 > income Statement > EBITDA
-9486767
Annuals > 2 > income Statement > operating Margin
-395.29252586761316
Annuals > 2 > income Statement > total Other Income Expense Net
2331929
Annuals > 2 > income Statement > currency_symbol
AUD
Annuals > 2 > balance Sheet > cash
4446102
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
92463
Annuals > 2 > balance Sheet > inventories
315122
Annuals > 2 > balance Sheet > total Current Assets
4988550
Annuals > 2 > balance Sheet > property Plant Equipment
4987072
Annuals > 2 > balance Sheet > total Assets
9975622
Annuals > 2 > balance Sheet > payables
325063
Annuals > 2 > balance Sheet > short Term Debt
1041051
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
5298126
Annuals > 2 > balance Sheet > equity
4677496
Annuals > 2 > balance Sheet > currency_symbol
AUD
Annuals > 2 > cash Flow > net Income
-9809193
Annuals > 2 > cash Flow > depreciation
1108183
Annuals > 2 > cash Flow > change In Working Capital
-29660
Annuals > 2 > cash Flow > cash From Operations
-8074214
Annuals > 2 > cash Flow > capital Expenditures
507315
Annuals > 2 > cash Flow > cash From Investing
-468727
Annuals > 2 > cash Flow > cash From Financing
-962061
Annuals > 2 > cash Flow > net Change In Cash
-8947665
Annuals > 2 > cash Flow > currency_symbol
AUD
Annuals > 2 > ratios > PE
-0.3499340831909194
Annuals > 2 > ratios > PB
0.05992852799874121
Annuals > 2 > ratios > ROE
-209.71034502220846
Annuals > 2 > ratios > ROA
-98.33164287901045
Annuals > 2 > ratios > FCF
-8581529
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.794444344944927
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2855566
Annuals > 3 > income Statement > cost Of Revenue
2704032
Annuals > 3 > income Statement > gross Profit
151534
Annuals > 3 > income Statement > operating Expenses
8466055
Annuals > 3 > income Statement > operating Income
-8314521
Annuals > 3 > income Statement > interest Expense
4302
Annuals > 3 > income Statement > pretax Income
-6024706
Annuals > 3 > income Statement > net Income
-6024706
Annuals > 3 > income Statement > eps
-0.23005344106291176
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
26188289
Annuals > 3 > income Statement > income Tax Expense
2614501
Annuals > 3 > income Statement > EBITDA
-5615967
Annuals > 3 > income Statement > operating Margin
-291.16893113309237
Annuals > 3 > income Statement > total Other Income Expense Net
2289815
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
13393768
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
31345
Annuals > 3 > balance Sheet > inventories
174534
Annuals > 3 > balance Sheet > total Current Assets
13769059
Annuals > 3 > balance Sheet > property Plant Equipment
346096
Annuals > 3 > balance Sheet > total Assets
14115155
Annuals > 3 > balance Sheet > payables
428278
Annuals > 3 > balance Sheet > short Term Debt
15141
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
809876
Annuals > 3 > balance Sheet > equity
13305279
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-6024706
Annuals > 3 > cash Flow > depreciation
404437
Annuals > 3 > cash Flow > change In Working Capital
48052
Annuals > 3 > cash Flow > cash From Operations
-5068491
Annuals > 3 > cash Flow > capital Expenditures
218833
Annuals > 3 > cash Flow > cash From Investing
-310093
Annuals > 3 > cash Flow > cash From Financing
5146038
Annuals > 3 > cash Flow > net Change In Cash
193221
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.23005344106291176
Annuals > 3 > ratios > PB
0.01968263048072874
Annuals > 3 > ratios > ROE
-45.28056871261399
Annuals > 3 > ratios > ROA
-42.68253519001385
Annuals > 3 > ratios > FCF
-5287324
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.8515852899215077
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.008251928695345665
Valuation > metrics > PB
-0.5208281015491255
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
42.97836356515634
Profitability > metrics > ROA
-180.70489324907822
Profitability > metrics > Net Margin
-64.56264086422631
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-2.594076929997802
Risk > final Score
20
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.1916170185539827
Liquidity > metrics > Quick Ratio
0.1916170185539827
Liquidity > final Score
20
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
37
Prev Risks > 1
27
Prev Risks > 2
-14
Prev Liquidities > 0
38
Prev Liquidities > 1
14
Prev Liquidities > 2
15
Updated At
2026-01-22T21:12:05.888Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
AUD
Earnings History > 1 > eps Actual
-0.0005
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0005
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
AUD
Earnings History > 2 > eps Actual
-0.0005
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0005
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
AUD
Earnings History > 3 > eps Actual
-0.0016
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0016
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
AUD
Earnings History > 4 > eps Actual
-0.0015
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.0015
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
AUD
Earnings History > 5 > eps Actual
-0.001
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.001
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
AUD
Earnings History > 6 > eps Actual
-0.0009
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0009
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
AUD
Earnings History > 7 > eps Actual
-0.0023
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.0023
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
AUD
Earnings History > 8 > eps Actual
-0.0023
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0023
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
AUD
Earnings History > 9 > eps Actual
-0.0011
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0011
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
AUD
Earnings History > 10 > eps Actual
-0.0011
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0011
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
AUD
Earnings History > 11 > eps Actual
-0.0061
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.0061
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
AUD
Earnings History > 12 > eps Actual
-0.0063
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0063
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
AUD
Earnings History > 13 > eps Actual
-0.0076
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0076
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
AUD
Earnings History > 14 > eps Actual
-0.0079
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0079
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-31
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
AUD
Earnings History > 15 > eps Actual
-0.007
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.007
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-09-30
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
AUD
Earnings History > 16 > eps Actual
-0.007
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.007
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-30
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
AUD
Earnings History > 17 > eps Actual
-0.0078
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0078
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
AUD
Earnings History > 18 > eps Actual
-0.0078
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0078
Earnings History > 18 > surprise Percent
-
Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It is involved in the nanotechnology; biotechnology; and cancer diagnostics businesses. The company develops MagSense, which completed Phase 1 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to detect cancer. The company has collaboration with Siemens MRI to support the Phase 2 study of MagSense HER2 imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Imagion Biosystems Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.0005
EPS Estimate
0
EPS Difference
-0.0005
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.